NICE Ltd. (FRA:NSY)

Intra-Cellular Therapies Revenue

NICE Ltd. had revenue of $700.19M USD in the quarter ending March 31, 2025, with 6.20% growth. This brings the company's revenue in the last twelve months to $2.78B, up 12.62% year-over-year. In the year 2024, NICE Ltd. had annual revenue of $2.74B with 15.05% growth.

• Revenue (ttm): $2.78B
• Revenue Growth: +12.62%
• P/S Ratio: 3.38
• Revenue / Employee: $318.15K
• Employees: 8,726
• Market Cap: 8.68B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.74B	357.76M	15.05%
Dec 31, 2023	2.38B	196.21M	9.00%
Dec 31, 2022	2.18B	260.14M	13.54%
Dec 31, 2021	1.92B	273.13M	16.57%
Dec 31, 2020	1.65B	74.10M	4.71%